Viewing Study NCT05469828


Ignite Creation Date: 2025-12-26 @ 11:12 AM
Ignite Modification Date: 2026-01-13 @ 8:51 AM
Study NCT ID: NCT05469828
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-08-30
First Post: 2021-08-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Crizanlizumab Improves Tissue Oxygen Supply Demand Matching in Patients With Sickle Cell Anemia
Sponsor: Children's Hospital Los Angeles
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sickle Cell Disease View
Keywords: